相关实验视频

Updated: Jun 27, 2025

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice

Published on: January 19, 2018

在受体介导,瘤向药物输送方面的进展

Danielle E Large¹, Jonathan R Soucy¹, Jacob Hebert¹

¹Department of Chemical Engineering, Northeastern University, 360 Huntington Ave., Boston, MA 02115, USA.

Advanced therapeutics

|May 3, 2024

概括

受体介导药物递送通过将药物向瘤,最大限度地减少副作用,从而增强癌症治疗效果. 这种方法利用特定的受体进行精确的药物积累和改善治疗结果.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

受体介导的药物递送提供了治疗药物在所需组织中的有针对性的积累,减少了非目标毒性.
癌细胞上的过度表达的受体作为向药物递送的平台,影响生物分布,毒性和治疗疗效.

研究的目的:

审查有前途的瘤向药物输送载体和受体,用于临床转化.
概述针对药物输送车辆的工程原理,考虑连接物,结合物和车辆类型.
讨论最近在多价值体向和连接体组织方面的进展,以增强瘤积累.

主要方法:

对瘤向药物递送系统的量化体外和体内数据的审查.
分析癌症中的受体过度表达作为向策略.
评估连接体设计,化学结合方法和药物输送载体类型.

主要成果:

鉴定具有临床转化潜力的药物输送载体和受体.
讨论工程定向交付系统的策略.
突出多价值向和连接体组织的进步,以改善瘤向.

结论:

受体介导的药物递送对增强癌症治疗具有显著的前景.
这种方法可以应用于提供化疗,基因编辑工具和表观遗传药物.
针对性交付工具和策略的进一步开发可能会彻底改变癌症治疗.

关键词:

癌症癌症癌症癌症癌症受体向受体向的目标有针对性的药物输送.这是一种治疗疗法.瘤的积累瘤的积累

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Transducer Mechanism: Enzyme-Linked Receptors

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: